| 1. |
N1-0331 |
A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases |
1/1/2024
-
12/31/2027 |
PhD Izidor Sosič
|
251 |
| 2. |
N1-0363 |
Bisphenol A substitutes: health risks to the endocrine and cardiovascular systems (Acronim: BPAsubRisk) |
3/1/2024
-
2/28/2027 |
PhD Marija Sollner Dolenc
|
659 |
| 3. |
J1-50038 |
New Hsp90 Inhibitor-based Therapies for Ewing Sarcoma |
1/1/2024
-
12/31/2026 |
PhD Tihomir Tomašić
|
374 |
| 4. |
J1-50023 |
3DfluorCO - Three-dimensional fluorine-based carbonyl bioisosteres: asymmetric synthesis and validation |
10/1/2023
-
9/30/2026 |
PhD Andrej Emanuel Cotman
|
1,045 |
| 5. |
J3-50099 |
A novel therapeutic strategy for allergic diseases based on epitope-paratope blocking |
10/1/2023
-
9/30/2026 |
PhD Peter Korošec
|
1,400 |
| 6. |
J3-50123 |
Bacterial Biofilm Formation Inhibitors: A Novel Approach to Combat Antimicrobial Resistance |
10/1/2023
-
9/30/2026 |
PhD Martina Hrast Rambaher
|
2,199 |
| 7. |
J1-50039 |
Breaking the Walls: Development of Inhibitors of D,D- and L,D-Transpeptidases |
10/1/2023
-
9/30/2026 |
PhD Stanislav Gobec
|
3,770 |
| 8. |
J1-50037 |
Development of CDK1-selective degraders for the treatment of T-cell malignancies |
10/1/2023
-
9/30/2026 |
PhD Izidor Sosič
|
1,093 |
| 9. |
L7-50044 |
Efficacy and safety of dietary supplementation in targeting sleep quality: an evidence-based approach for supporting informed choices |
10/1/2023
-
9/30/2026 |
PhD Igor Pravst
|
3,705 |
| 10. |
J3-50116 |
Matters of the heart: elucidating the cardiotoxic mechanism of proteasome inhibitors |
10/1/2023
-
9/30/2026 |
PhD Martina Gobec
|
2,210 |
| 11. |
J4-50139 |
Valorization of Himalayan balsam (Impatiens glandulifera Royle) waste to design bioactive extracts with a potential protective activity on the human vascular system |
10/1/2023
-
9/30/2026 |
PhD Alen Albreht
|
1,340 |
| 12. |
BI-FR/24-25-PROTEUS-003 |
Antibiotic adjuvants: translocation of boron-containing β-lactamase inhibitors via OmpF/OmpC porin channels and their subcellular quantification in Enterobacteria |
1/1/2024
-
12/31/2025 |
PhD Alen Krajnc
|
32 |
| 13. |
BI-FR/24-25-PROTEUS-002 |
Identification of low molecular weight inhibitors for the development of new antibacterial drugs |
1/1/2024
-
12/31/2025 |
PhD Rok Frlan
|
113 |
| 14. |
N1-0277 |
Research of multifunctional compounds targeting neuroinflammation and cholinergic deficit in Alzheimer's disease |
1/1/2023
-
12/31/2025 |
PhD Stanislav Gobec
|
1,060 |
| 15. |
L4-4564 |
Biotehnological potential of selected microorganisms from Sečovlje Saltpans for application in cosmetics products |
10/1/2022
-
9/30/2025 |
PhD Ana Rotter
|
2,740 |
| 16. |
J1-4417 |
Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy |
10/1/2022
-
9/30/2025 |
PhD Matej Sova
|
3,919 |
| 17. |
J1-4402 |
Dynamical model of a type II DNA topoisomerase biological nanomachine and design of catalytic inhibitors |
10/1/2022
-
9/30/2025 |
PhD Andrej Perdih
|
2,610 |
| 18. |
J1-4400 |
Evaluation of transient protein states |
10/1/2022
-
9/30/2025 |
PhD Simona Golič Grdadolnik
|
3,213 |
| 19. |
J3-4499 |
MECHANISMS OF RESPONSE TO INTERLEUKIN 12/23 BLOCKERS IN ULCERATIVE COLITS – TOWARDS PERSONALIZED MEDICINE |
10/1/2022
-
9/30/2025 |
PhD David Drobne
|
2,551 |
| 20. |
J7-4635 |
MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy |
10/1/2022
-
9/30/2025 |
PhD Lucija Peterlin Mašič
|
6,051 |
| 21. |
J3-4527 |
Muscle cell secretom and bone cells interplay in osteosarcopenia (MiKOSA) |
10/1/2022
-
9/30/2025 |
PhD Janja Marc
|
3,551 |
| 22. |
J7-4418 |
Nanofibers for codelivery of selected microbiota cocktails and antimicrobials for local treatment of vaginal infections |
10/1/2022
-
9/30/2025 |
PhD Špela Zupančič
|
5,267 |
| 23. |
J4-4556 |
New biofertilization approach based on the microbial multispecies biocatalytic aggregates |
10/1/2022
-
9/30/2025 |
PhD Tomaž Rijavec
|
6,340 |
| 24. |
J3-4496 |
Next-generation adjuvants for mucosal vaccines |
10/1/2022
-
9/30/2025 |
PhD Žiga Jakopin
|
1,196 |
| 25. |
J1-4414 |
ProBiS-Fold approach for binding site detection for whole structural human proteome in drug discovery |
10/1/2022
-
9/30/2025 |
PhD Dušanka Janežič
|
2,045 |
| 26. |
L2-4455 |
Quantitative light scattering spectroscopy as a process analytical technology in pharmaceutical manufacturing |
10/1/2022
-
9/30/2025 |
PhD Franjo Pernuš
|
2,581 |
| 27. |
J2-4480 |
Removal of selected antimicrobials by plasma-cavitation hybrid technology from water matrices of varying complexity (Causma) |
10/1/2022
-
9/30/2025 |
PhD Martin Petkovšek
|
2,695 |
| 28. |
J7-4420 |
Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles |
10/1/2022
-
9/30/2025 |
PhD Aleš Berlec
|
3,817 |
| 29. |
BI-RS/23-25-016 |
Confronting multidrug-resistant Acinetobacter baumanii infection by DNA gyrase and topoisomerase inhibitors |
7/1/2023
-
6/30/2025 |
PhD Žiga Jakopin
|
195 |
| 30. |
BI-RS/23-25-018 |
The use of active cosmetic ingredients from botanical origin for lowering the synthetic preserves in cosmetic products |
7/1/2023
-
6/30/2025 |
PhD Samo Kreft
|
779 |
| 31. |
BI-HR/23-24-031 |
Development of nanomedicines with poorly soluble drugs for ocular application |
4/1/2023
-
3/31/2025 |
PhD Petra Kocbek
|
295 |
| 32. |
BI-HR/23-24-032 |
Evaluation of harmine analogues as potential Hsp90 inhibitors against pediatric sarcomas |
4/1/2023
-
3/31/2025 |
PhD Tihomir Tomašić
|
374 |
| 33. |
BI-TR/22-24-007 |
Antimicrobial activity evaluation of natural and synthetic cinnamic acid derivatives against human and fish pathogens and their potential use as additives in fish feed |
1/1/2023
-
12/31/2024 |
PhD Matej Sova
|
163 |
| 34. |
BI-DE/23-24-011 |
Computer-aided design, synthesis and biological evaluation of Toll-like receptor 8 modulators |
1/1/2023
-
12/31/2024 |
PhD Matej Sova
|
163 |
| 35. |
BI-FR/23-24-PROTEUS-002 |
Development of effective reactivators of organophosphate-inhibited butyrylcholinesterase |
1/1/2023
-
12/31/2024 |
PhD Damijan Knez
|
198 |
| 36. |
BI-AT/23-24-008 |
Development of Hsp90 C-terminal domain inhibitors for the treatment of pediatric sarcomas |
1/1/2023
-
12/31/2024 |
PhD Tihomir Tomašić
|
374 |
| 37. |
BI-DE/23-24-009 |
New mitochondrial ion channels Kv1.3 inhibitors as inducers of apoptosis |
1/1/2023
-
12/31/2024 |
PhD Lucija Peterlin Mašič
|
407 |
| 38. |
BI-ME/23-24-030 |
Non-Alcoholic Fatty Liver Disease in adolescents and its association with oxidative stress, inflammation and genetic factors |
1/1/2023
-
12/31/2024 |
PhD Barbara Ostanek
|
189 |
| 39. |
J3-3079 |
Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms |
12/1/2021
-
11/30/2024 |
PhD Stane Pajk
|
2,397 |
| 40. |
Z1-4405 |
Development of new antibiotics simultaneously targeting beta-lactamases and penicillin-binding proteins |
10/1/2022
-
9/30/2024 |
PhD Alen Krajnc
|
32 |
| 41. |
J1-3021 |
A synthetic biofilm-based platform for studying and development of new antibiofilm strategies |
10/1/2021
-
9/30/2024 |
PhD Iztok Dogša
|
1,412 |
| 42. |
J3-3062 |
Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer |
10/1/2021
-
9/30/2024 |
PhD Matjaž Jeras
|
2,522 |
| 43. |
J3-3071 |
Cathepsins B and X in breast cancer stem cells – molecular targets and relevance for antitumor therapy |
10/1/2021
-
9/30/2024 |
PhD Ana Mitrović
|
2,653 |
| 44. |
J4-3092 |
Development of biologically active and chemically stable xanthophylls based on a sustainable esterification of xanthophylls from renewable natural resources |
10/1/2021
-
9/30/2024 |
PhD Alen Albreht
|
1,385 |
| 45. |
L1-3160 |
Development of highly concentrated protein formulations and evaluation of absorption kinetics after subcutaneous administration |
10/1/2021
-
9/30/2024 |
PhD Iztok Grabnar
|
2,929 |
| 46. |
J1-3031 |
Development of new inhibitors of bacterial topoisomerases to overcome antimicrobial resistance |
10/1/2021
-
9/30/2024 |
PhD Nace Zidar
|
1,033 |
| 47. |
J2-3043 |
Exploitation of the magneto-mechanical effect in the treatment of neurodegenerative diseases |
10/1/2021
-
9/30/2024 |
PhD Slavko Kralj
|
4,404 |
| 48. |
J1-3030 |
MTAvsAMR: new MultiTargeting Antibiotics against AntiMicrobial Resistance |
10/1/2021
-
9/30/2024 |
PhD Lucija Peterlin Mašič
|
955 |
| 49. |
J4-3096 |
Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile |
10/1/2021
-
9/30/2024 |
PhD Borut Štrukelj
|
3,036 |
| 50. |
L3-3177 |
Safety evaluation of cannabidiols and implications for public health and consumers behaviour |
10/1/2021
-
9/30/2024 |
|
4,835 |
| 51. |
J1-3018 |
Smart probes for ex vivo assay-based early prediction of Alzheimer disease |
10/1/2021
-
9/30/2024 |
PhD Janez Košmrlj
|
2,196 |
| 52. |
L3-3176 |
The Role and Potential Application of Immunomodulatory Mesenchymal Stem Cells in COVID-
19 Disease |
10/1/2021
-
9/30/2024 |
PhD Janja Zupan
|
3,398 |
| 53. |
BI-US/22-24-182 |
Characterization of NOD2 receptor ligand binding |
7/1/2022
-
6/30/2024 |
PhD Žiga Jakopin
|
195 |
| 54. |
BI-US/22-24-004 |
Optimization of selective butyrylcholine esterase inhibitors as potential therapeutic agents for heroin abuse therapy |
7/1/2022
-
6/30/2024 |
PhD Damijan Knez
|
198 |
| 55. |
N1-0172 |
Fotokemijski pristop za odkrivanje naprednih ATP-kompetitivnih prob z zaviralnim delovanjem na Topoizomerazo IIalfa (Slovene) |
1/1/2021
-
12/31/2023 |
PhD Janez Ilaš
|
739 |
| 56. |
N1-0169 |
Kovalentni pristop k boju proti bakterijski rezistenci (Slovene) |
1/1/2021
-
12/31/2023 |
PhD Stanislav Gobec
|
1,180 |
| 57. |
J3-2517 |
Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants |
9/1/2020
-
12/31/2023 |
PhD Žiga Jakopin
|
2,205 |
| 58. |
J1-2484 |
Development of antibacterial compounds targeting validated enzymes in peptidoglycan biosynthesis |
9/1/2020
-
8/31/2023 |
PhD Stanislav Gobec
|
3,864 |
| 59. |
J7-2603 |
EFFICACY OF BACTERIOPHAGES FOR TREATEMENT OF EXTRACELULAR AND INTRACELULAR BACTERIAL INFECTIONS OF IMPLANTANTS |
9/1/2020
-
8/31/2023 |
PhD Aleš Podgornik
|
2,301 |
| 60. |
J3-2521 |
Inflammatory process in interstitial cystitis and evaluation of the influence of cannabinoid receptor agonists in urinary bladder - from cells to patients |
9/1/2020
-
8/31/2023 |
PhD Peter Veranič
|
3,822 |
| 61. |
J1-2483 |
Radiopharmaceuticals with antagonistic activity on CCK2R |
9/1/2020
-
8/31/2023 |
PhD Marko Anderluh
|
1,054 |
| 62. |
J3-2518 |
Role of APOBEC proteins in the oncogenesis of HPV viruses |
9/1/2020
-
8/31/2023 |
PhD Martina Bergant Marušič
|
1,193 |
| 63. |
J1-2485 |
The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs |
9/1/2020
-
8/31/2023 |
PhD Izidor Sosič
|
953 |
| 64. |
J1-1717 |
Development of novel Hsp90 inhibitors with anticancer activity |
7/1/2019
-
6/30/2023 |
PhD Tihomir Tomašić
|
1,893 |
| 65. |
J3-1745 |
Elucidating the role of immunoproteasome in platelet-driven immune response |
7/1/2019
-
6/30/2023 |
PhD Martina Gobec
|
1,123 |
| 66. |
J3-1749 |
Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system |
7/1/2019
-
6/30/2023 |
PhD Janja Zupan
|
2,345 |
| 67. |
J1-1709 |
Strukturni vpogled v mehanizem tvorbe površine bakterije Clostridium difficile |
7/1/2019
-
6/30/2023 |
PhD Dušan Turk
|
2,159 |
| 68. |
J4-1778 |
Exploitation of a virus-borne small protein to combat antibiotic resistance in Staphylococcus aureus |
7/1/2019
-
12/31/2022 |
PhD Matej Butala
|
3,381 |
| 69. |
N1-0098 |
Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity |
1/1/2019
-
12/31/2022 |
PhD Lucija Peterlin Mašič
|
885 |
| 70. |
V4-2038 |
DNA vaccine and peptide inhibitors against SARS-CoV-2 |
10/1/2020
-
9/30/2022 |
PhD Roman Jerala
|
8,222 |
| 71. |
Z1-2635 |
Modular asymmetric total synthesis of bioactive multi-chiral natural products |
9/1/2020
-
8/31/2022 |
PhD Andrej Emanuel Cotman
|
57 |
| 72. |
J3-1759 |
Comprehensive characterization of GWAS hits – pipeline to novel drug targets for anabolic treatment of osteoporosis
(GWASforAna) |
7/1/2019
-
6/30/2022 |
PhD Janja Marc
|
4,736 |
| 73. |
J4-1776 |
Improvement of immunotherapeutic potential of NK cells through modulation of cystatin F |
7/1/2019
-
6/30/2022 |
PhD Janko Kos
|
2,923 |
| 74. |
J1-1715 |
Protein interaction atlas for prediction of genetic variations involved in drug interactions and disease development |
7/1/2019
-
6/30/2022 |
PhD Dušanka Janežič
|
2,548 |
| 75. |
J4-1767 |
Selective extraction of high value molecules from forest products processing residues in the
speciality chemicals sector |
7/1/2019
-
6/30/2022 |
PhD Andreja Kutnar
|
4,053 |
| 76. |
J3-9256 |
Development of NOD2 agonists and dual NOD2/TLR7 agonistic conjugates as novel vaccine adjuvants |
7/1/2018
-
6/30/2022 |
PhD Žiga Jakopin
|
2,804 |
| 77. |
J1-9194 |
Nanomedicines with antibiotics and probiotics for local treatment of periodontal disease |
7/1/2018
-
6/30/2022 |
PhD Julijana Kristl
|
3,431 |
| 78. |
Z1-1859 |
Targeted covalent inhibitors: inhibiting monoamine oxidase through non-catalytic amino-acid residues |
7/1/2019
-
6/30/2021 |
PhD Damijan Knez
|
198 |
| 79. |
J3-9267 |
Inhibition of cathepsin X activity as a novel strategy for the treatment of Parkinson's disease |
7/1/2018
-
6/30/2021 |
PhD Anja Pišlar
|
2,723 |
| 80. |
J1-9192 |
New anticancer leads for emerging cancer target potassium ion channels hEag1 and its validation in lymphoma tumors
|
7/1/2018
-
6/30/2021 |
PhD Lucija Peterlin Mašič
|
2,195 |
| 81. |
J4-9327 |
Targeting, imaging and treating of colorectal cancer with safe theranostic bacteria |
7/1/2018
-
6/30/2021 |
PhD Aleš Berlec
|
2,468 |
| 82. |
NC-0009 |
Development of new carbamate-based imaging probes for cholinesterases |
4/1/2019
-
3/31/2021 |
PhD Stanislav Gobec
|
1,053 |
| 83. |
V1-1914 |
Selection and preparation of a dossier potentially neurotoxic chemical using in silico methods for the purpose of implementing the European chemical legislation REACH |
11/1/2019
-
10/31/2020 |
PhD Marjan Vračko - Grobelšek
|
928 |
| 84. |
N1-0068 |
Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods |
11/1/2017
-
10/31/2020 |
PhD Stanislav Gobec
|
1,803 |
| 85. |
Z1-9195 |
Butyrylcholinesterase inhibitors for alleviating symptoms of Alzheimer's disease |
7/1/2018
-
6/30/2020 |
PhD Urban Košak
|
58 |
| 86. |
NC-0004 |
NOBIL - Novel Biomarkers in Leukemia |
5/1/2018
-
4/30/2020 |
PhD Irena Mlinarič Raščan
|
775 |
| 87. |
J4-8227 |
Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy
|
5/1/2017
-
4/30/2020 |
PhD Janko Kos
|
4,553 |
| 88. |
L1-8157 |
Development of multifunctional compounds for treatment of Alzheimer's disease |
5/1/2017
-
4/30/2020 |
PhD Stanislav Gobec
|
4,690 |
| 89. |
J1-8145 |
Dynamic aspect of ligand-protein binding |
5/1/2017
-
4/30/2020 |
PhD Simona Golič Grdadolnik
|
1,749 |
| 90. |
J1-8140 |
Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for
environmental hazard in zdravje ljudi |
5/1/2017
-
4/30/2020 |
PhD Metka Filipič
|
3,739 |
| 91. |
J1-8152 |
Inhibition of Staphylococcus aureus cell wall remodeling |
5/1/2017
-
4/30/2020 |
PhD Dušan Turk
|
1,976 |
| 92. |
J3-8207 |
New frontiers in folate supplementation in obstetrics and gynaecology (NFFS OB-GYN) |
5/1/2017
-
4/30/2020 |
PhD Ksenija Geršak
|
4,977 |
| 93. |
J3-8210 |
Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention |
5/1/2017
-
4/30/2020 |
PhD Mirza Šabovič
|
2,432 |
| 94. |
V4-1605 |
The use of hop products for organic control of varroa (Varroa destructor) |
10/1/2016
-
9/30/2019 |
PhD Iztok Jože Košir
|
3,119 |
| 95. |
Z1-8158 |
Discovery of new inhibitors of bacterial peptidoglycan biosynthesis enzymes MurA and MurB |
5/1/2017
-
4/30/2019 |
PhD Marko Jukič
|
171 |
| 96. |
L2-7550 |
Elecrospun nanofibrous materials for solid state drug delivery system |
3/1/2016
-
2/28/2019 |
PhD Igor Emri
|
4,425 |
| 97. |
J4-7640 |
Electrostatic immobilisation of bacterial cells and effects on their physiology |
3/1/2016
-
2/28/2019 |
PhD Aleš Lapanje
|
7,054 |
| 98. |
J3-7245 |
Identification of new expression regulators of RANKL, a key molecule not only in bone remodelling |
1/1/2016
-
12/31/2018 |
PhD Janja Marc
|
2,690 |
| 99. |
J1-7302 |
Nanotheranostics based on magneto-responsive materials |
1/1/2016
-
12/31/2018 |
PhD Petra Kocbek
|
3,901 |
| 100. |
J1-7515 |
Receptors for toxins of plant pathogens |
1/1/2016
-
12/31/2018 |
PhD Gregor Anderluh
|
3,836 |
| 101. |
J1-7479 |
Structural insight into iodine metabolism |
1/1/2016
-
12/31/2018 |
PhD Dušan Turk
|
1,765 |
| 102. |
J3-7494 |
Tunneling nanotubes for innovative urinary bladder cancer treatments |
1/1/2016
-
12/31/2018 |
PhD Mateja Erdani Kreft
|
7,081 |
| 103. |
V3-1636 |
New psychoactive substances monitoring system in Slovenia
(acronym SONDA) |
10/1/2016
-
9/30/2018 |
PhD Miran Brvar
|
1,489 |
| 104. |
Z1-7181 |
Optimization of nitroxoline-based inhibitors of cathepsin B as potential drugs for the treatment of cancer |
1/1/2016
-
12/31/2017 |
PhD Izidor Sosič
|
251 |
| 105. |
L1-6745 |
Combating bacterial resistance: optimisation of bacterial cell wall biosynthesis inhibitors |
7/1/2014
-
6/30/2017 |
PhD Stanislav Gobec
|
3,233 |
| 106. |
J1-6743 |
Computational tools development for modeling of pharmaceutically interesting molecules |
7/1/2014
-
6/30/2017 |
PhD Dušanka Janežič
|
2,705 |
| 107. |
J1-6744 |
Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis |
7/1/2014
-
6/30/2017 |
PhD Tina Kosjek
|
4,810 |
| 108. |
J1-6746 |
Intra-pocket-targeted nanomedicines for treatment of periodontal disease |
7/1/2014
-
6/30/2017 |
PhD Julijana Kristl
|
3,901 |
| 109. |
J4-6811 |
The role of cysteine protease inhibitors in NK cell mediated lysis of tumour cells |
7/1/2014
-
6/30/2017 |
PhD Janko Kos
|
2,438 |
| 110. |
J3-6792 |
TRANS TIO
Translational pharmacogenomic research of thiopurine therapy |
7/1/2014
-
6/30/2017 |
PhD Irena Mlinarič Raščan
|
1,598 |
| 111. |
J3-5507 |
ANALYSIS OF FOLATE METABOLISM BIOMARKERS IN THE RISK ASSESSMENT FOR NEURAL TUBE DEFECTS |
8/1/2013
-
7/31/2016 |
PhD Ksenija Geršak
|
3,613 |
| 112. |
J3-5502 |
Dysregulation of TDP-43 expression in amyotrophic lateral sclerosis and frontotemporal lobar degeneration |
8/1/2013
-
7/31/2016 |
PhD Boris Rogelj
|
5,278 |
| 113. |
J3-5511 |
Micro RNA – new diagnostic and therapeutic targerts in osteoporosis |
8/1/2013
-
7/31/2016 |
PhD Janez Preželj
|
1,719 |
| 114. |
J4-5529 |
Nitroxoline and its derivatives as new antitumour drugs |
8/1/2013
-
7/31/2016 |
PhD Janko Kos
|
5,950 |
| 115. |
J1-5450 |
Protein engineering of recombinant probiotic lactic acid bacteria for treatment of irritative bowel disease |
8/1/2013
-
7/31/2016 |
PhD Borut Štrukelj
|
2,442 |
| 116. |
Z1-5458 |
Design, synthesis, and evaluation of new voltage-gated sodium channels modulators |
8/1/2013
-
7/31/2015 |
PhD Nace Zidar
|
219 |
| 117. |
L2-4072 |
Complex hyperspectral system for automatic analysis and control of pharmaceutical pellet coating processes |
7/1/2011
-
6/30/2014 |
PhD Boštjan Likar
|
2,253 |
| 118. |
J1-4236 |
Design, formulation and characterization of biomimetic nanocomposite systems for effective tissue regeneration |
7/1/2011
-
6/30/2014 |
PhD Julijana Kristl
|
5,051 |
| 119. |
J3-4285 |
Development and evaluation of radiolabelled bio-molecules for targeted radionuclide therapy and imaging of neuroendocrine tumours |
7/1/2011
-
6/30/2014 |
PhD Jurij Fettich
|
2,352 |
| 120. |
J4-4123 |
Inhibitors of cysteine carboxypeptidases as regulators of autoimmune and neurodegenerative processes |
7/1/2011
-
6/30/2014 |
PhD Janko Kos
|
6,318 |
| 121. |
L1-4039 |
Preclinical development of new antibacterial drugs |
7/1/2011
-
6/30/2014 |
PhD Stanislav Gobec
|
4,141 |
| 122. |
J3-4313 |
The influence of active transport and patients' genotypes on the therapeutic outcome of chronic myeloic leukemia |
7/1/2011
-
6/30/2014 |
PhD Albin Kristl
|
3,122 |
| 123. |
L6-4045 |
Theoretical and practical Aspects of Terminology and Terminography in Connection with Internet Terminological Resources |
7/1/2011
-
6/30/2014 |
PhD Andreja Žele
|
4,088 |
| 124. |
J3-4220 |
The role of genetic polymorphisms in treatment result and occurance of side effects in children with cancer |
7/1/2011
-
6/30/2014 |
PhD Janez Jazbec
|
3,350 |
| 125. |
J3-4026 |
Transport and RNA binding of TDP-43 and FUS - implications for ALS/FTLD spectrum of neurodegenerative disease |
7/1/2011
-
6/30/2014 |
PhD Boris Rogelj
|
4,614 |
| 126. |
J3-3615 |
Pharmacogenetic approaches to research, diagnosis and therapy of leukemia |
5/1/2010
-
4/30/2013 |
PhD Irena Mlinarič Raščan
|
2,121 |
| 127. |
J3-2330 |
Genetski dejavniki pri osteoporozi (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Janja Marc
|
2,289 |
| 128. |
J4-2212 |
Glivni citokromi P450, vključeni v detoksifikacijo rastlinskih obramnih spojin, kot tarče novih protiglivnih učinkovin (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Nada Kraševec
|
3,742 |
| 129. |
J3-2356 |
Izrazanje in funkcionalna analiza nekodirajocih RNA pri parkinsonovi bolezni (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Boris Rogelj
|
4,364 |
| 130. |
L3-2293 |
Zaščitni pleiotropni učinki nizkih odmerkov zaviralcev sistema renin-angiotenzin in statinov pri zdravi populaciji srednjih let (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Mirza Šabovič
|
3,691 |
| 131. |
L3-0129 |
Cell-free nucleic acids in diagnosis of coronary atherosclerosis |
2/1/2008
-
1/30/2011 |
PhD Darko Černe
|
2,043 |
| 132. |
J7-0337 |
Formulation and characterization of fuzogenic colloidal nanoparticles for efficient drug delivery into cells |
2/1/2008
-
1/30/2011 |
PhD Marjeta Šentjurc
|
1,544 |
| 133. |
J3-0488 |
Functional analysis of non-coding RNAs in Parkinson's disease |
2/1/2008
-
1/30/2011 |
PhD Boris Rogelj
|
2,339 |
| 134. |
L3-0431 |
Genetics of breast cancer and hormone replacement therapy |
2/1/2008
-
1/30/2011 |
PhD Ksenija Geršak
|
3,745 |
| 135. |
J7-0474 |
New Report on Condition of Knowledge in Developed Societies – 30 Years after Jean-François Lyotard’s Analysisew Report on Knowledge |
2/1/2008
-
1/30/2011 |
PhD Mladen Dolar
|
3,154 |
| 136. |
L4-1046 |
NOVEL BIOTECH DRUG SUBSTANCES BY USING PHAGE DISPLAY TECHNOLOGY |
2/1/2008
-
1/30/2011 |
PhD Borut Štrukelj
|
3,940 |
| 137. |
J1-0957 |
Pharmacogenetic study of raloxifene metabolism and transport |
2/1/2008
-
1/30/2011 |
PhD Aleš Mrhar
|
1,948 |
| 138. |
L3-0636 |
Preparation and evaluation of stabilised control blood for haematology analysers in Slovenian external quality assessment scheme (SNEQAS). |
2/1/2008
-
1/30/2011 |
PhD Milan Skitek
|
1,139 |
| 139. |
L6-0075 |
Slovenian Terminology in Connection with Internet Language Resources |
2/1/2008
-
1/30/2011 |
PhD Andreja Žele
|
2,915 |
| 140. |
J7-9704 |
NQR - nondestructive method for studying of polymorphism in heteregeneous pharmaceutical systems |
7/1/2007
-
6/30/2010 |
PhD Zvonko Trontelj
|
4,598 |
| 141. |
J4-9425 |
Lectins as modulators of anti-tumour immune response |
1/1/2007
-
12/31/2009 |
PhD Janko Kos
|
2,213 |
| 142. |
J4-7062 |
Proteomics as a tool for monitoring biosynthesis processes |
9/1/2005
-
8/31/2008 |
PhD Janko Kos
|
5,974 |
| 143. |
J1-7363 |
Role of the proteolytic systems in the malignancy of brain tumour stem cells. |
9/1/2005
-
8/31/2008 |
PhD Irena Zajc
|
3,434 |
| 144. |
J3-7406 |
Thiopurine pharmacogenetics
- novel diagnostics and individualized therapy |
9/1/2005
-
8/31/2008 |
PhD Irena Mlinarič Raščan
|
2,595 |
| 145. |
M4-0124 |
Prehranski dodatki za optimalno prehrano v ekstremnih razmerah (Slovene) |
6/1/2006
-
11/30/2007 |
PhD Samo Kreft
|
4,015 |
| 146. |
J3-6429 |
Genetski dejavniki reproduktivnega zdravja ženske (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Ksenija Geršak
|
3,389 |
| 147. |
J1-6356 |
Use of inorganic particles for particle design and their potential application in systems with modified release |
7/1/2004
-
6/30/2007 |
PhD Marjan Bele
|
2,640 |
| 148. |
L1-6707 |
Design, synthesis and test of potencial hypolipidemic drugs with a new target |
2/1/2004
-
1/30/2007 |
PhD Uroš Urleb
|
3,384 |
| 149. |
L1-6711 |
Development of a technological procedure for preparation of biologicaly active hop extract enriched with xanthohumol |
7/1/2004
-
6/30/2006 |
PhD Tamara Lah Turnšek
|
5,932 |
| 150. |
Z1-6451 |
Mehanizem povečanja permeabilnosti sečnega mehurja s hitosanom (Slovene) |
7/1/2004
-
6/30/2006 |
PhD Danijel Kikelj
|
811 |
| 151. |
Z4-6096 |
Peptide ligands as novel biopharmaceutics by using phage display technology |
2/1/2004
-
1/30/2006 |
PhD Borut Štrukelj
|
1,344 |
| 152. |
L1-5267 |
Analysis of gene expression associated with apoptosis using microarrays |
1/1/2003
-
12/31/2005 |
PhD Irena Mlinarič Raščan
|
717 |
| 153. |
L3-5309 |
Analysis of gene expression associated with apoptosis using microarrays |
1/1/2003
-
12/31/2005 |
PhD Irena Mlinarič Raščan
|
1,130 |
| 154. |
L1-5094 |
Determination of surface properties of solid and semisolid materials by solid and semisolid materials with inverse phase gas chromatography |
1/1/2003
-
12/31/2005 |
PhD Stanko Srčič
|
2,839 |
| 155. |
L3-5084 |
Peptidominetiki - inhibitorji koagulacije krvi in agregacije trombocitov (Slovene) |
1/1/2003
-
12/31/2005 |
PhD Mojca Stegnar
|
5,539 |
| 156. |
L4-4090 |
Optimizacija kakovosti zdravilnih rastlin (Echinacea purpurea Moench., Gentiana lutea L., Hypericum perforatum L.) v pridelovanju (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Dea Baričevič
|
2,414 |
| 157. |
Z1-3238 |
Genetic and environmental risk factors for bone remodelation disturbances |
7/1/2001
-
6/30/2004 |
PhD Samo Kreft
|
2,082 |
| 158. |
J3-3395 |
Genetic causes of female infertility 2
|
7/1/2001
-
6/30/2004 |
PhD Ksenija Geršak
|
4,577 |
| 159. |
J3-3314 |
Genetic factors and hormones in metabolic diseases |
7/1/2001
-
6/30/2004 |
PhD Andreja Kocijančič
|
4,936 |
| 160. |
L1-3261 |
Development of biologicaly active peptidomimetics |
7/1/2001
-
12/31/2003 |
PhD Uroš Urleb
|
2,061 |
| 161. |
V4-0476 |
Ekotoksikološki, rezidualni in ekonomski vidiki uporabe avermektinskih zdravil pri drobnici (Slovene) |
1/1/2002
-
10/31/2003 |
PhD Vesna Cerkvenik Flajs
|
4,888 |
| 162. |
L1-2129 |
Raziskave uporabnost proste površinske energije pri trdnih farmacevtskih sistemih (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Franc Vrečer
|
2,325 |
| 163. |
L3-2003 |
Razvoj rutinskih metod za dolocanje presnovkov galaktoze in genotipizacijo galaktozemij (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Tadej Battelino
|
3,068 |
| 164. |
L1-1381 |
Biofarmacevtske lastnosti, sinteza in aktivnost spojin kinolonov s kovinskimi atomi (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Albin Kristl
|
5,155 |
| 165. |
L4-1301 |
Proučevanje aktualnih kužnih bolezni pri živalih z uporabo sodobnih imunoloških, biokemijskih in molekularnih metod (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Darja Barlič Maganja
|
8,857 |
| 166. |
J2-1537 |
Reološke lastnosti in ostali transportni procesi hidrofilnih polimerov (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Miha Žumer
|
3,166 |
| 167. |
J1-0572 |
Interakcije bioaktivnih ligandov v sistemih rastoče kompleksnosti (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Aleš Mrhar
|
5,597 |
| 168. |
L4-0827 |
Tkivne kulture za proizvodnjo sekundarnih metabolitov (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Jana Žel
|
3,102 |
| 169. |
J1-7377 |
Protivirusne spojine: transport in interakcije v biosistemih (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Albin Kristl
|
2,698 |
| 170. |
J3-7880 |
Ugotavljanje biokemičnih in elektrofizioloških parametrov pri kronično bolnih otrocih in mladostnikih (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Ciril Kržišnik
|
5,697 |
| 171. |
V4-9128 |
Uporaba rastlinske biotehnologije za varstvo rastlin (razvoj identifikacijskih metod za rastlinske patogene in ovrednotenje transgenih (Slovene) |
10/1/1997
-
9/30/2000 |
PhD Maja Ravnikar
|
6,455 |
| 172. |
L1-0469 |
Optimization of MDP and TNF analogues having therapeutic potential |
7/1/1998
-
6/30/2000 |
PhD Anton Štalc
|
6,237 |
| 173. |
J1-8889 |
Mimetics of biologically active peptides: Strategies of design and synthesis |
1/1/1997
-
12/31/1999 |
PhD Danijel Kikelj
|
3,854 |
| 174. |
J1-8891 |
Synthesis, identification, and properties of potential pharmaceuticals |
1/1/1997
-
12/31/1999 |
PhD Andrej Petrič
|
1,885 |
| 175. |
L1-8890 |
Raziskave hidrodinamsko uravnoteženih farmacevtskih oblik z nadzorovanim sproščanjem (Slovene) |
1/1/1997
-
12/31/1998 |
PhD Franc Vrečer
|
1,964 |
| 176. |
L4-7355 |
Alternativno koriščenje za slovenijo perspektivnih zdravilnih in aromatičnih rastlin in njihovo vrednotenje (Slovene) |
1/1/1996
-
12/31/1998 |
PhD Dea Baričevič
|
1,663 |
| 177. |
L1-7823 |
Lastnosti in sinteza organokovinskih spojin z biološko učinkovitostjo (Slovene) |
1/1/1996
-
12/31/1998 |
PhD Stanislav Primožič
|
6,730 |
| 178. |
L2-7632 |
Spektralno selektivne energetsko efektne prevleke za solarne namene (Slovene) |
1/1/1996
-
12/31/1998 |
PhD Boris Orel
|
2,473 |
| 179. |
L1-7379 |
Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene) |
1/1/1996
-
6/30/1998 |
PhD Anton Štalc
|
6,017 |
| 180. |
J1-7053 |
Selektivni ligandi: sinteza, interakcije z makromolekulami in transport v biosistemih (Slovene) |
1/1/1995
-
6/30/1998 |
PhD Aleš Mrhar
|
7,060 |
| 181. |
J3-7200 |
Uporabnost kvalitativne metode za vrednotenje bolnikovega jemanja zdravil (Slovene) |
1/1/1995
-
6/30/1998 |
PhD Jelka Šmid-Korbar
|
563 |
